MDM2 and neuroblastoma: However, a recent study analyzing MDM2 promotor SNP309 in 496 neuroblastoma patients, a single nucleotide polymorphism in the MDM2 promotor that was shown to increase MDM2 expression [33], did not find an association between this polymorphism and overall or event-free survival [34].